NEURONES PRESS INFORMATION
Heading: 1st half 2015 results
Nanterre, September 9, 2015
1st half 2015 operating profit stands at 8.6%
| Accounts at 30 June (audited and in € millions) | H1 2015 | H1 2014 | 2014 |
| Revenues | 195.5 | 177.1 | 355.2 |
| Business operating profit (*) | 17.2 (8.8%) | 16.5 (9.3%) | 36,5 (10.3%) |
| Operating profit | 16.8 (8.6%) | 16.1 (9.1%) | 35.5 (10.0%) |
| Net financial profit | 0.9 | 1.1 | 1.7 |
| Corporate income tax | (6.5) | (6.4) | (13.6) |
| Net profit after tax | 11.2 (5.7%) | 10.8 (6.1%) | 23.6 (6.6%) |
| of which, group share | 9.7 | 9.4 | 20.5 |
| Staff at end of period | 4,377 | 4,016 | 4,082 |
(*) Prior to cost of bonus shares, stock options and impairment of assets.
Achievements
The Group showed solid growth of 10.4% in the first half (+9.6% with constant structures).
Operating profit increased by 4.2% to account for 8.6% of revenues.
The Group's net cash also grew to €119 million, compared with €100.8 million on June 30, 2014.
Outlook
Overall, for 2015, NEURONES maintains its forecast to achieve annual revenues of €380 million and an operating profit in excess of 9% of revenues.
About NEURONES
With around 4,400 experts, the NEURONES group is specialized in Consulting (Management and Organization) and IT Services (Infrastructures and Applications). It supports its clients in their change-management projects and in the upgrading and outsourcing of their Information Systems.
Euronext Paris (Compartment B - NRO) - Enternext Tech 40 - PEA-PME Eligible - SRD medium values
www.neurones.net:
http://www.neurones.net/
| Press relations: Florence Gillier Communication Sabine Grosdidier Tel.: +33 (0)1 41 18 85 55 sabineg@fgcom.fr: mailto:sabineg@fgcom.fr | NEURONES Matthieu VAUTIER Tel.: +33 (0)1 41 37 41 37 rp@neurones.net: mailto:rp@neurones.net | Investor relations: NEURONES Paul-César BONNEL Tel.: +33 (0)1 41 37 41 37 investisseurs@neurones.net: mailto:investisseurs@neurones.net |
http://hugin.info/143513/R/1950879/709371.pdf
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: NEURONES via Globenewswire
